Ignite Creation Date:
2025-12-18 @ 8:36 AM
Ignite Modification Date:
2025-12-23 @ 9:49 PM
Study NCT ID:
NCT04510285
Status:
None
Last Update Posted:
2023-02-01 00:00:00
First Post:
2020-08-10 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection
Sponsor:
Organization:
Raw JSON
{}